Akero Therapeutics Inc (AKRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKRO | KROS | SRRK | ||
| Company | Akero Therapeutics Inc | Keros Therapeutics Inc | Scholar Rock Holding Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 31.76 | 60.00 | 27.88 | ||
| High | 32.25 | 62.00 | 27.98 | ||
| Low | 31.12 | 59.47 | 26.89 | ||
| Last | 31.58 | 61.84 | 27.42 | ||
| Change | -0.47 | +1.89 | -0.25 | ||
| % Change | -1.47% | +3.15% | -0.90% | ||
| Volume | 90,126 | 103,592 | 192,145 | ||
| 20-Day Average Volume | 496,688 | 304,014 | 1,782,216 | ||
| Previous Close | 32.05 | 59.95 | 27.67 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 30.32 | 59.94 | 28.78 | ||
| 20-Day Raw Stochastic | 74.41% | 79.97% | 48.62% | ||
| 20-Day Relative Strength | 58.86% | 58.91% | 61.86% | ||
| Weighted Alpha | +104.12 | +86.73 | -26.07 | ||
| Today's Opinion | 100% Buy | 88% Buy | 72% Buy | ||
| Previous Opinion | 100% Buy | 80% Buy | 72% Buy | ||
| Last Month's Opinion | 80% Buy | 56% Buy | 16% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.57% since 10/29/24 | +2.26% since 10/29/24 | -11.02% since 10/29/24 | ||
| Low | 30.13 on 10/31/24 | 57.53 on 11/04/24 | 26.89 on 11/05/24 | ||
| High | 32.95 on 11/01/24 | 61.86 on 11/05/24 | 31.17 on 10/30/24 | ||
| 1-Month | |||||
| %Chg | +11.72% since 10/04/24 | +0.99% since 10/04/24 | +270.89% since 10/04/24 | ||
| Low | 26.46 on 10/07/24 | 56.79 on 10/10/24 | 24.00 on 10/10/24 | ||
| High | 32.95 on 11/01/24 | 62.68 on 10/28/24 | 35.38 on 10/08/24 | ||
| 3-Month | |||||
| %Chg | +32.56% since 08/05/24 | +30.27% since 08/05/24 | +228.01% since 08/05/24 | ||
| Low | 23.42 on 08/06/24 | 42.83 on 08/08/24 | 6.76 on 10/03/24 | ||
| High | 32.95 on 11/01/24 | 62.68 on 10/28/24 | 35.38 on 10/08/24 | ||
| 6-Month | |||||
| %Chg | +60.48% since 05/03/24 | +1.54% since 05/03/24 | +79.28% since 05/03/24 | ||
| Low | 17.86 on 06/05/24 | 40.93 on 07/09/24 | 6.76 on 10/03/24 | ||
| High | 32.95 on 11/01/24 | 62.68 on 10/28/24 | 35.38 on 10/08/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,225,263 | 2,249,444 | 2,214,513 | ||
| Shares Outstanding, K | 69,431 | 37,522 | 80,033 | ||
| Annual Sales | 0 | 150,000 | 0 | ||
| Annual Net Income | -151,760,000 | -152,990,000 | -165,790,000 | ||
| Last Quarter Sales | 0 | 40,000 | 0 | ||
| Last Quarter Net Income | -55,990,000 | -45,260,000 | -58,510,000 | ||
| 60-Month Beta | -0.26 | 1.23 | 0.47 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.81 on 08/09/24 | -1.25 on 08/07/24 | -0.60 on 08/08/24 | ||
| Latest Earnings Date | 11/11/24 | 11/04/24 | 11/12/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||